Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts.
Neilan AM, Losina E, Bangs AC, Flanagan C, Panella C, Eskibozkurt GE, Mohareb A, Hyle EP, Scott JA, Weinstein MC, Siedner MJ, Reddy KP, Harling G, Freedberg KA, Shebl FM, Kazemian P, Ciaranello AL.
Neilan AM, et al. Among authors: ciaranello al.
Clin Infect Dis. 2021 Nov 2;73(9):e2908-e2917. doi: 10.1093/cid/ciaa1418.
Clin Infect Dis. 2021.
PMID: 32945845
Free PMC article.